Therefore, RET mutation carriers should be operated as soon as possible at a young age, especially those carrying a H-risk RET mutation, and when Ct levels are within normal range, to avoid once and for all the risk of developing MTC and a possible relapse of the disease that may occur even at long-term. This evidence concerns the gene RET and medullary thyroid gland carcinoma.